• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Am Med Dir Assoc . The Effect of Age on Mortality in Patients With COVID-19: A Meta-Analysis With 611,583 Subjects

tetano

Editor, Senior Moderator
J Am Med Dir Assoc


. 2020 Jul;21(7):915-918.
doi: 10.1016/j.jamda.2020.05.045. Epub 2020 May 25.
The Effect of Age on Mortality in Patients With COVID-19: A Meta-Analysis With 611,583 Subjects


Clara Bonanad[SUP] 1 [/SUP], Sergio Garc?a-Blas[SUP] 2 [/SUP], Francisco Tarazona-Santabalbina[SUP] 3 [/SUP], Juan Sanchis[SUP] 2 [/SUP], Vicente Bertomeu-Gonz?lez[SUP] 4 [/SUP], Lorenzo F?cila[SUP] 5 [/SUP], Albert Ariza[SUP] 6 [/SUP], Julio N??ez[SUP] 2 [/SUP], Alberto Cordero[SUP] 7 [/SUP]



Affiliations

Abstract

Objectives: Initial data on COVID-19 infection has pointed out a special vulnerability of older adults.
Design: We performed a meta-analysis with available national reports on May 7, 2020 from China, Italy, Spain, United Kingdom, and New York State. Analyses were performed by a random effects model, and sensitivity analyses were performed for the identification of potential sources of heterogeneity.
Setting and participants: COVID-19-positive patients reported in literature and national reports.
Measures: All-cause mortality by age.
Results: A total of 611,1583 subjects were analyzed and 141,745 (23.2%) were aged ≥80 years. The percentage of octogenarians was different in the 5 registries, the lowest being in China (3.2%) and the highest in the United Kingdom and New York State. The overall mortality rate was 12.10% and it varied widely between countries, the lowest being in China (3.1%) and the highest in the United Kingdom (20.8%) and New York State (20.99%). Mortality was <1.1% in patients aged <50 years and it increased exponentially after that age in the 5 national registries. As expected, the highest mortality rate was observed in patients aged ≥80 years. All age groups had significantly higher mortality compared with the immediately younger age group. The largest increase in mortality risk was observed in patients aged 60 to 69 years compared with those aged 50 to 59 years (odds ratio 3.13, 95% confidence interval 2.61-3.76).
Conclusions and implications: This meta-analysis with more than half million of COVID-19 patients from different countries highlights the determinant effect of age on mortality with the relevant thresholds on age >50 years and, especially, >60 years. Older adult patients should be prioritized in the implementation of preventive measures.

Keywords: COVID-19; coronavirus; mortality; older adults.
 
Back
Top Bottom